Back
Apogee Therapeutics Vs. RH Industry Stock Comparison
Sell
21
APGE
Apogee Therapeutics
Last Price:
$47.53
Seasonality Move:
132.82%
Buy
64
RH
RH
Last Price:
$405.18
Seasonality Move:
-4.26%
Sell
21
Apogee Therapeutics (APGE)
is a Sell
Is Apogee Therapeutics a Buy, Sell or Hold?
-
The current Apogee Therapeutics [APGE] share price is $47.77. The Score for APGE is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
APGE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
APGE Stock Price Chart
What is Apogee Therapeutics's stock price today?
-
The Apogee Therapeutics share price today is $47.77The current trend is relatively stagnant and APGE is experiencing slight selling pressure.
APGE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.64 | Sell |
Relative Strength Index (14 RSI): | 51.04 | Buy |
Chaikin Money Flow: | -9117 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.11 - 48.79) | Buy |
Bollinger Bands (100): | (46 - 55.62) | Sell |
RH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.35 | Buy |
Relative Strength Index (14 RSI): | 56.55 | Buy |
Chaikin Money Flow: | 311777 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (379.48 - 411.46) | Buy |
Bollinger Bands (100): | (282.95 - 381.69) | Buy |
APGE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.58 | Buy |
20-day SMA: | 46.98 | Buy |
50-day SMA: | 49.51 | Sell |
200-day SMA: | 49.75 | Sell |
8-day EMA: | 46.66 | Buy |
20-day EMA: | 46.99 | Buy |
50-day EMA: | 48.59 | Sell |
200-day EMA: | 46.03 | Buy |
RH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 401.89 | Buy |
20-day SMA: | 399.03 | Buy |
50-day SMA: | 364.22 | Buy |
200-day SMA: | 298.98 | Buy |
8-day EMA: | 399.99 | Buy |
20-day EMA: | 394.55 | Buy |
50-day EMA: | 371.42 | Buy |
200-day EMA: | 317.06 | Buy |
Apogee Therapeutics Earnings Growth & APGE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.97 per share, and a decrease next year of $0.70 per share.
RH Earnings Growth & RH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.54 per share, a decrease next quarter of $0.79 per share, a decrease this year of $2.09 per share, and an increase next year of $6.94 per share.
Apogee Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
RH Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |